Press release
Impact Of Increasing Cancer And Cardiovascular Disease Prevalence On The Growth Of The Generic Injectable Market: A Key Factor Shaping the Future of the Generic Injectables Market in 2025
Generic Injectables Market Size
The escalating occurrence of cancer and cardiovascular ailments is set to fuel an increase in the generic injectable market in the future. The term cardiovascular diseases encompasses various disorders affecting the heart and blood vessels, while cancer is defined as a disease where the body's cells multiply uncontrollably and spread elsewhere in the body. Generic injectables have a crucial role in treating cancer and cardiac diseases as they offer similar pharmaceutical equivalence or bioequivalence to brand drugs. They also increase the availability and accessibility of drugs, making treatment more affordable. The World Health Organization reported in September 2022, 41 million deaths, accounting for 74% of deaths caused by noncommunicable diseases (NCDs) or chronic diseases worldwide each year. Among these, 17.9 million were due to cardiovascular diseases, 9.3 million were due to cancer, 4.1 million from chronic respiratory diseases, and 2.0 million were due to diabetes. Consequently, the increasing incidence of cancer and cardiovascular diseases is stimulating the expansion of the generic injectable market.
Get Your Generic Injectables Market Report Here:
https://www.thebusinessresearchcompany.com/report/generic-injectables-global-market-report
What is the projected compound annual growth rate (CAGR) of the generic injectables market from 2025 to 2034, and what factors influence it?
In the past few years, the size of the generic injectables market has seen a swift expansion. It is projected to increase from $124.61 billion in 2024 to $143.13 billion in 2025, presenting a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this growth during the historic period include cost-effectiveness, expiry of patents, initiatives regarding healthcare access, competition in the market, and prevailing global pharmaceutical trends.
In the forthcoming years, the generic injectables market size is anticipated to undergo swift expansion. It is projected to garner a valuation of "$238.43 billion by 2029, with a compound annual growth rate (CAGR) of 13.6%. The expansion during the forecast period is owed to factors such as a growing elderly population, strategic collaborations, regulatory modifications, heightened healthcare awareness, and market innovation. During the forecast period, significant trends include an emphasis on quality and regulatory adherence, utilization of the 505 (b) (2) regulatory pathway, introduction of unique drug delivery tech, collaboration and partnerships within the sector, and an elevated concentration on specialty injectable treatments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
How are the latest trends influencing the growth of the generic injectables market?
The emergence of product innovations is a significant trend being observed in the generic injectables market. To maintain their standing in this market, major corporations are progressing with their generic injectables. In a specific example from April 2022, Dr. Reddy's Laboratories, a pharmaceutical company based in India, released its Treprostinil Injection to the U.S. market. This medication is a generic equivalent to Remodulin (treprostinil) Injection, which has received approval from the U. S. Food and Drug Administration (USFDA), a U.S.-based entity. Its application is designed for patients in need of a transition from epoprostenol to decrease the speed of clinical degradation.
What are the major segments of the generic injectables market and their role in driving growth?
The generic injectables market covered in this report is segmented -
1) By Product Type: Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Other Products
2) By Container Type: Vials, Ampoules, Premix, Prefilled Syringes, Other Containers
3) By Route Of Administration: Intravenous, Intramuscular, Subcutaneous, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores
5) By Application: Oncology, Diabetes , Infectious Diseases , Blood Disorders , Musculoskeletal Disorders , Hormonal Disorders , Pain Management , CNS Diseases , Cardiovascular Diseases
Subsegments:
1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies, Other Types Of Monoclonal Antibodies
2) By Cytokines: Interferons, Interleukins, Tumor Necrosis Factor (TNF) Inhibitors
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin
4) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
5) By Other Products: Hormones, Peptides, Enzymes
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10776
Which regions are key players in the growth of the generic injectables market?
North America was the largest region in the generic injectable market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generic injectables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the generic injectables market?
Major companies operating in the generic injectables market include Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Merck & Co. Inc., Biocon Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Samsung Biologics Co. Ltd., Piramal Pharma Limited, Bristol-Myers Squibb Company, Pfizer Inc., Hikma Pharmaceuticals PLC, Par Pharmaceutical, Pharmascience Inc., SAGENT Pharmaceuticals, AmerisourceBergen Corporation, Hospira Inc., Sandoz International GmbH, Singota Solutions Inc., MVASI Bevacizumab-awwb Syringes, Mylan N.V., Sun Pharmaceutical Industries Ltd., Endo International plc, Akorn Pharmaceuticals Inc., Wockhardt Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
What Is Covered In The Generic Injectables Global Market Report?
• Market Size Forecast: Examine the generic injectables market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the generic injectables market for a structured understanding.
• Key Players Overview: Analyze major players in the generic injectables market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the generic injectables market.
• Segment Contributions: Evaluate how different segments drive overall growth in the generic injectables market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the generic injectables market.
• Industry Challenges: Identify potential risks and obstacles affecting the generic injectables market.
• Competitive Landscape: Review strategic developments in the generic injectables market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Increasing Cancer And Cardiovascular Disease Prevalence On The Growth Of The Generic Injectable Market: A Key Factor Shaping the Future of the Generic Injectables Market in 2025 here
News-ID: 3893227 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
